ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $58 | -40.8% | 36,699 | +133.0% | 0.01% | -50.0% |
Q4 2022 | $98 | -99.9% | 15,753 | +1.0% | 0.01% | +25.0% |
Q1 2022 | $72,000 | -13.3% | 15,598 | -5.9% | 0.01% | -11.1% |
Q4 2021 | $83,000 | -79.2% | 16,570 | +93.1% | 0.01% | -86.6% |
Q2 2019 | $399,000 | +21.3% | 8,580 | +4.8% | 0.07% | +24.1% |
Q1 2019 | $329,000 | -53.5% | 8,190 | -42.0% | 0.05% | -53.0% |
Q3 2017 | $707,000 | – | 14,110 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |